
Gemfibrozil Tablets
| Product/Composition | Gemfibrozil Tablets |
|---|---|
| Strength | 150mg. 300mg, 600mg |
| Form | Tablet |
| Production Capacity | 10 Million Tablets/Month |
| Packaging | 10 X 10 Tablets / Box |
| Therapeutic use | Cardiovascular |
| Package Insert/Leaflet | Available upon request |
Gemfibrozil Tablets are a medicine used to manage abnormal blood lipid levels, especially high triglycerides. They belong to a class of drugs called fibrates.
Here are the key details:
-
Composition: Each tablet contains Gemfibrozil, commonly in 600 mg strength.
-
Dosage Form: Oral tablets, usually taken twice daily, 30 minutes before meals, as prescribed by a doctor.
-
Mode of Action:
-
Gemfibrozil activates peroxisome proliferator-activated receptor alpha (PPARα) in the liver.
-
This increases the breakdown of triglycerides, lowers very low-density lipoprotein (VLDL), and can modestly raise high-density lipoprotein (HDL) cholesterol.
-
-
Uses:
-
Hypertriglyceridemia – very high triglyceride levels to reduce risk of pancreatitis.
-
Mixed dyslipidemia – high cholesterol with high triglycerides.
-
Often used when diet and lifestyle changes alone are insufficient to control lipid levels.
-
-
Treatment Goal: To lower triglycerides, improve cholesterol balance, and reduce cardiovascular risk.
-
Side Effects:
-
Common: stomach discomfort, nausea, diarrhea, headache, dizziness.
-
Less common/serious: liver function changes, gallstones, muscle pain or weakness (myopathy), allergic reactions.
-
-
Precautions:
-
Regular monitoring of liver function, kidney function, and blood lipid levels is recommended.
-
Use caution in patients with liver, kidney, or gallbladder disease.
-
Avoid combining with certain statins without doctor supervision due to increased risk of muscle damage.
-
Maintain a healthy diet and lifestyle alongside medication for optimal results.
-
👉 Gemfibrozil is effective for controlling high triglycerides and improving lipid profiles, especially in patients at risk for pancreatitis or cardiovascular disease.